|
ZNF654 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63426999999494E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.50200000000167E-05 |
| Normal-vs-Stage2 |
5.149800E-02 |
| Normal-vs-Stage3 |
1.976670E-03 |
| Normal-vs-Stage4 |
6.41900000000195E-05 |
| Stage1-vs-Stage2 |
9.752800E-01 |
| Stage1-vs-Stage3 |
4.574200E-01 |
| Stage1-vs-Stage4 |
2.681400E-01 |
| Stage2-vs-Stage3 |
6.236600E-01 |
| Stage2-vs-Stage4 |
3.647000E-01 |
| Stage3-vs-Stage4 |
5.552600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26159999997078E-06 |
| Normal-vs-AfricanAmerican |
1.117780E-02 |
| Normal-vs-Asian |
2.455300E-03 |
| Caucasian-vs-AfricanAmerican |
5.143600E-01 |
| Caucasian-vs-Asian |
7.236800E-01 |
| AfricanAmerican-vs-Asian |
3.014000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47449999987614E-07 |
| Normal-vs-Female |
2.777800E-01 |
| Male-vs-Female |
5.404400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.678000E-03 |
| Normal-vs-Extreme_Weight |
1.38179999997767E-07 |
| Normal-vs-Obese |
3.955100E-03 |
| Normal-vs-Extreme_Obese |
1.171220E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.726200E-01 |
| Normal_Weight-vs-Obese |
6.430600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.287400E-01 |
| Extreme_Weight-vs-Obese |
5.459500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.743000E-01 |
| Obese-vs-Extreme_Obese |
6.831600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.343800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.220300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.95609999997792E-06 |
| Normal-vs-Age(81-100Yrs) |
2.19700000003709E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.547800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.536200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.501500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.535510E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.741000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.39340000000632E-05 |
| Normal-VS-Type2 PRCC |
4.65259997195488E-09 |
| Normal-VS-KIRP CIMP |
2.338800E-01 |
| Normal-VS-Unclassified PRCC |
2.168400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.718000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.125000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.914800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.398200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.426000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.060000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.23140003644085E-09 |
| Normal-vs-N1 |
2.690300E-02 |
| Normal-vs-N2 |
5.63089999999766E-05 |
| N0-vs-N1 |
7.476000E-02 |
| N0-vs-N2 |
3.431800E-01 |
| N1-vs-N2 |
1.534980E-01 |
|
|
